These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17606200)

  • 1. Cytoreductive surgery for gynecologic malignancies--new standards of care.
    Suh-Burgmann E; Powell CB
    Surg Oncol Clin N Am; 2007 Jul; 16(3):667-82, x-xi. PubMed ID: 17606200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoreductive surgery and intraoperative hyperthermic chemoperfusion for advanced ovarian carcinoma.
    Reichman TW; Cracchiolo B; Sama J; Bryan M; Harrison J; Pliner L; Harrison LE
    J Surg Oncol; 2005 May; 90(2):51-6; discussion 56-8. PubMed ID: 15844187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
    Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
    Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?
    Eisenkop SM; Spirtos NM
    Gynecol Oncol; 2001 Sep; 82(3):489-97. PubMed ID: 11520145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Up-date on cytoreductive surgery in the management of advanced ovarian cancer].
    Angioli R; Palaia I; Damiani P; Montera R; Benedetti Panici P
    Minerva Ginecol; 2006 Dec; 58(6):459-70. PubMed ID: 17108876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer.
    Sugarbaker PH
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):15-24. PubMed ID: 19124999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
    Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
    Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.
    Pavlov MJ; Kovacevic PA; Ceranic MS; Stamenkovic AB; Ivanovic AM; Kecmanovic DM
    Eur J Surg Oncol; 2009 Nov; 35(11):1186-91. PubMed ID: 19356887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
    Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
    Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery in ovarian cancer: the concept of cytoreductive surgery.
    Peter A; Heintz M
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):8-11. PubMed ID: 8777265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoreductive surgery for recurrent ovarian cancer.
    Hauspy J; Covens A
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):15-21. PubMed ID: 17218846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intraperitoneal chemotherapy for ovarian cancer].
    Noma J; Yoshida N
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):885-90. PubMed ID: 18633214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Optimal" cytoreduction for advanced epithelial ovarian cancer: a commentary.
    Eisenkop SM; Spirtos NM; Lin WC
    Gynecol Oncol; 2006 Oct; 103(1):329-35. PubMed ID: 16876853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer.
    Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Aghajanian C; Barakat RR; Chi DS
    Gynecol Oncol; 2008 Feb; 108(2):276-81. PubMed ID: 18063020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New treatment concepts for gynecologic pelvic malignancies: neoadjuvant therapies.
    Restivo A; Gordinier M; Granai CO
    Surg Oncol Clin N Am; 2005 Apr; 14(2):239-47. PubMed ID: 15817237
    [No Abstract]   [Full Text] [Related]  

  • 16. Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study.
    Fagotti A; Paris I; Grimolizzi F; Fanfani F; Vizzielli G; Naldini A; Scambia G
    Gynecol Oncol; 2009 Jun; 113(3):335-40. PubMed ID: 19345401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon resection for ovarian cancer: intraoperative decisions.
    Hoffman MS; Zervose E
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S56-65. PubMed ID: 18835022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A third evaluation of tertiary cytoreduction.
    Gultekin M; Velipaşaoğlu M; Aksan G; Dursun P; Dogan NU; Yuce K; Ayhan A
    J Surg Oncol; 2008 Dec; 98(7):530-4. PubMed ID: 18937233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. Preliminary results and cost from two centers in Greece.
    Spiliotis J; Tentes AA; Vaxevanidou A; Korakianitis OS; Rogdakis A; Mirelis CG; Datsis AC; Kekelos S
    J BUON; 2008; 13(2):205-10. PubMed ID: 18555466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer.
    Almadrones L
    Clin J Oncol Nurs; 2007 Apr; 11(2):211-6. PubMed ID: 17573270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.